San Francisco-based Vera Health has raised $28.5 million in Series A funding to expand an AI-powered clinical search engine that helps doctors find and evaluate medical evidence.
The round was led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient increased their commitments, bringing the company's total funding to $32 million.
The financing follows rapid adoption. Vera says more than 800,000 clinicians across 190 countries use its platform, up from only a few thousand approximately one year ago.
The company reports achieving that reach with a team of just 12 employees.
What Vera Health Actually Does
Vera is designed to help clinicians answer medical questions using published research, clinical guidelines and drug information.
Its platform searches more than 60 million scientific publications and medical references, according to the company.
A doctor might use Vera to examine treatment recommendations, investigate an uncommon diagnosis or compare clinical evidence concerning a medication.
The central distinction is how the platform constructs its answers.
Rather than relying only on a language model's internal knowledge, Vera retrieves relevant scientific material before generating a response.
Individual claims are linked to supporting sources, allowing clinicians to inspect the underlying evidence.
The platform also uses color-coded indicators to communicate the strength of available research.
A recommendation supported by established clinical guidelines should not be presented with the same certainty as one derived from a small observational study or individual case report.
Vera is attempting to make those differences visible.
The system also prioritizes locally relevant medical guidelines, recognizing that treatment practices and regulatory standards differ between countries.
Through a partnership with the American College of Emergency Physicians, Vera integrates the organization's clinical policies with source attribution.
Who Founded Vera Health?
Vera was co-founded by Taieb Bennani and Maxime Allouch.
Bennani has a background in bioengineering and data science, including studies at Yale and MIT. Allouch brings experience spanning artificial intelligence and business, including MIT and HEC Paris.
The founders initially developed the product around the needs of physicians in their families.
That focus shaped the company's product philosophy: clinicians need rapid access to reliable evidence, not simply fluent answers.
Vera participated in Y Combinator's Summer 2024 program.
How Fast Is Vera Growing?
The company's reported usage growth is unusual for a clinical application.
Vera says it reaches approximately one in four physicians in Spain and Italy and one in seven in France.
It also reports being the most downloaded clinical application worldwide across major mobile app stores during several consecutive months in 2026, citing third-party download data.
Most users reportedly discover the platform through recommendations from colleagues.
However, downloads and registered clinicians do not establish the same level of active engagement.
The company has not publicly disclosed a complete breakdown of paying customers, active-user retention, revenue or gross margins.
Vera says it will remain free for licensed clinicians and medical students.
Its longer-term commercial model has not been fully described in the announcement.
Competition in Clinical AI Search
Vera operates in an increasingly competitive market.
OpenEvidence has developed an AI-based medical research platform, while established products such as UpToDate and Elsevier's ClinicalKey provide medical reference and decision-support tools.
Doximity has also introduced AI capabilities for healthcare professionals.
Vera's emphasis is on traceable evidence, transparent uncertainty and international clinical relevance.
These features address a fundamental weakness of general-purpose AI systems: they can produce convincing medical explanations even when supporting evidence is incomplete or contradictory.
However, attaching citations does not automatically make an answer medically correct.
The underlying research may be outdated, inapplicable to a specific patient or interpreted incorrectly.
What Comes Next?
The new funding will support medical evidence infrastructure, geographic expansion and partnerships with healthcare organizations.
Vera must demonstrate that its research retrieval and evidence-ranking systems improve clinical decision-making, not merely answer questions faster.
Independent evaluations, clinician retention and measurable workflow benefits will be important.
The company must also navigate clinical safety, privacy and regulatory requirements as its software becomes more integrated into patient care.
Vera's opportunity is to become a trusted interface between medical research and daily clinical practice. Its biggest challenge is proving that its answers remain reliable across specialties, languages and healthcare systems.